View the partner profile
| Organization name: | Management Sciences for Health |
| Organization type: | NGO - International Health |
| Website: | http://www.msh.org |
| Description: | The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program is a follow on to the Strengthening Pharmaceutical Systems (SPS) program. SPS has been a major USAID mechanism for providing technical leadership in pharmaceutical management for tuberculosis to Global TB initiatives, donors, Stop TB partners, and national TB programs. The SIAPS Global TB Portfolio aims to strengthen pharmaceutical management systems that meet Global TB Goals:-
1) Strengthen DOTS
2) Scale up prevention and treatment of Drug-Resistant TB
3) Expedite adoption and implementation of new TB tools
4) Improve health systems through development and use of frameworks, guidelines and successful application of management information systems for TB
Additional technical focus area(s):
• Pharmaceutical system assessments, options analysis and strategic planning;
• development of tools, guidelines, standard operating procedures and manuals;
• quantification, forecasting and supply planning;
• adaptation and design of management information systems for improved decision making;
• design and implementation of data collection forms and tools for decision making;
• rational medicine use and medicine safety;
• building local coalitions for containing drug resistance and a methodology for indicator-based drug utilization reviews;
|
| Contact name: | Niranjan Konduri |
| Contact email: | nkonduri@msh.org |
|
| Technical focus area(s): |
Drug Procurement and Supply Management
General TB experts
Health System's Strengthening
|
|
| Current projects with TB component: | The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program |
|
| Countries with TB-related work currently underway: |
Bangladesh
Cambodia
Kenya
Namibia
Nigeria
Pakistan
Philippines
South Africa
Ukraine
United Republic of Tanzania
Uzbekistan
Viet Nam
|
|
| List of countries in which you have offices: |
Afghanistan
Bangladesh
Benin
Burundi
Cameroon
Cote d'Ivoire
Democratic Republic of the Congo
Ethiopia
Kenya
Lesotho
Liberia
Mali
Namibia
Rwanda
Senegal
South Africa
Swaziland
Uganda
Ukraine
United Republic of Tanzania
United States of America
Viet Nam - Contact Email: gnguyen@msh.org
Zambia
|
|
| Illustrative list of TA providers and areas of expertise: | Andre Zagorski
• strengthening pharmaceutical management systems for TB control programs
• project management, implementation and evaluation
• health systems strengthening and policy
• supply chain management; development of pharmaceutical management tools and use of tools developed by MSH
• management information systems
• monitoring and evaluation
• development of training courses and capacity building programs
Antonia Kwiecien
• developing and implementing instruments to improve the rational use of medicines for the treatment of DR-TB
• providing training on pharmaceutical management systems for TB
• improving and promoting e-TB Manager - a comprehensive web-based TB case-centered tool for managing TB programs
Dr. Archil Salakaia
• technical expert on behalf of Global Drug Facility (GDF) of Stop TB Partnership and WHO
• programmatic Management of TB and DR-TB
• pharmaceutical Management of anti-TB drugs
• TB control program’s needs assessment and planning
• TB information systems
Ms. Chinwe Owunna
• TB-HIV collaboration
• pharmaceutical system assessments, options analysis and strategic planning;
• quantification, forecasting and supply planning
• development of tools, guidelines, standard operating procedures and manuals
• warehousing and inventory management
• rational use of medicines (prescribing, dispensing, patient use, adherence, medicines safety)
• design and implementation of data collection forms and tools for decision making
• curriculum development and capacity building in pharmaceutical management
Dr. Edmund Rutta’s
• strengthening pharmaceutical management systems for TB control programs
• health systems strengthening and policy
• increasing access to essential medicines and services in the private sector [private clinics/hospitals, pharmacies, and drug shops]
• promoting public-private partnership and improving the quality of services; harnessing the private sector potential to increase access to essential services
• creating referral linkages between the public and private sector providers at various levels
• TB in refugee population and in prison
• monitoring and evaluation
Dr. Joel Keravec
• strengthening DOTS implementation and multidrug-resistant TB (MDR-TB) control
• over 10 years of experience in technical assistance to the national TB programs in Europe, Asia and Africa to strengthen MDR-TB Programs, second line drug management and information systems
• improved product management information systems [e-TB Manager system www.etbmanager.org]
• serves as a Global Drug Facility Technical Review Committee member and Global Green Light Committee member
• pharmaceutical management of product quality assurance and international quality standards/systems for medicine quality testing and clinical laboratories
• selection of essential medicines for standardized TB treatment; improved policy and regulatory environment for essential medicines
• managerial expertise encompasses public sector management, health systems strengthening, strategic planning, cost monitoring, epidemiology and monitoring and evaluation
Niranjan Konduri
• operations research and framework development to guide technical activities in pharmaceutical policy and management
• pharmaceutical sector analysis to guide market access strategies for new TB technologies
• development of a framework for the Adoption, Introduction and Implementation of New TB Technologies
• Engaging stakeholders for TB prevention and control
• Operational planning before introduction of any new TB technologies
• rational use of first-line and second-line TB medicines (prescribing, dispensing, patient use, adherence, medicines safety)
|
|
| Date created: | 12 January 2011 8:34 |
| Date last modified: | 7 February 2013 14:46 |
| |
|
|
